Author

Michele Caraglia

Professore Ordinario di Biochimica, Universit

Biography

Graduated from Toho Academy of Music in Tokyo, as a pianist and composer, invited by the Boston Symphony, she came to the USA in 1961 as one of the first Japanese women. She then received Master of Art from New York University and finished her Ph.D. credits in Philosophy in 1965. In 1967, Tatsumura then turned to an independent career and became the top International Classical and Cultural Impresario/producer. Until 1992, she produced an average of 2,000 cultural events each year, traveling to more
Title
Cited by
Year
Microsatellite instability: from the implementation of the detection to a prognostic and predictive role in cancers
M Amato, R Franco, G Facchini, R Addeo, F Ciardiello, M Berretta, G Vita, ...International Journal of Molecular Sciences 23 (15), 8726, 2022202
18
2022
Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide
G Di Lorenzo, S Zappavigna, F Crocetto, M Giuliano, D Ribera, R Morra, ...Clinical Genitourinary Cancer 19 (5), e286-e298, 2021202
16
2021
p53: from fundamental biology to clinical applications in cancer
M Capuozzo, M Santorsola, M Bocchetti, F Perri, M Cascella, V Granata, ...Biology 11 (9), 1325, 2022202
14
2022
MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer
C Ferri, A Di Biase, M Bocchetti, S Zappavigna, S Wagner, P Le Vu, ...Journal of Experimental & Clinical Cancer Research 41 (1), 1-16, 2022202
13
2022
Role of miRNA-145, 148, and 185 and stem cells in prostate cancer
D Coradduzza, S Cruciani, C Arru, G Garroni, A Pashchenko, M Jedea, ...International journal of molecular sciences 23 (3), 1626, 2022202
13
2022
Safety and efficacy evaluation in vivo of a cationic nucleolipid nanosystem for the nanodelivery of a Ruthenium (III) complex with superior anticancer bioactivity
M Piccolo, MG Ferraro, F Raucci, C Riccardi, A Saviano, I Russo Krauss, ...Cancers 13 (20), 5164, 2021202
12
2021
Long-term neuropathic pain behaviors correlate with synaptic plasticity and limbic circuit alteration: a comparative observational study in mice
F Guida, M Iannotta, G Misso, F Ricciardi, S Boccella, V Tirino, M Falco, ...Pain 163 (8), 1590, 2022202
12
2022
Overview on molecular biomarkers for laryngeal cancer: looking for new answers to an old problem
M Falco, C Tammaro, T Takeuchi, AM Cossu, G Scafuro, S Zappavigna, ...Cancers 14 (7), 1716, 2022202
11
2022
Metastatic colorectal cancer and type 2 diabetes: prognostic and genetic interactions
A Ottaiano, L Circelli, M Santorsola, G Savarese, D Fontanella, ...Molecular oncology 16 (2), 319-332, 2022202
8
2022
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: A single academic institution experience
V Caputo, V De Falco, A Ventriglia, V Famiglietti, E Martinelli, F Morgillo, ...Therapeutic Advances in Medical Oncology 14, 158835922109688, 2022202
7
2022
Potential mechanisms by which glucocorticoids induce breast carcinogenesis through Nrf2 inhibition
A Giudice, SM Aliberti, A Barbieri, P Pentangelo, I Bisogno, G D’Arena, ...Frontiers in Bioscience-Landmark 2 (), 223, 2022202
7
2022
Clinical and molecular characteristics of rare malignant tumors of colon and rectum
A Ottaiano, M Santorsola, F Perri, U Pace, B Marra, M Correra, ...Biology 11 (2), 27, 2022202
6
2022
BK virus infection and BK-Virus-Associated nephropathy in renal transplant recipients
M Borriello, D Ingrosso, AF Perna, A Lombardi, P Maggi, L Altucci, ...Genes 13 (7), 1290, 2022202
6
2022
Clinical utility of liquid biopsy to detect BRAF and NRAS mutations in stage III/IV Melanoma patients by using real-time PCR
EF Giunta, V De Falco, PP Vitiello, LP Guerrera, G Suarato, R Napolitano, ...Cancers 14 (13), 3053, 2022202
6
2022
Microsatellite status detection in gastrointestinal cancers: PCR/NGS is mandatory in negative/patchy MMR immunohistochemistry
F Zito Marino, M Amato, A Ronchi, I Panarese, F Ferraraccio, F De Vita, ...Cancers 14 (9), 2204, 2022202
5
2022
Characterization of KRAS Mutational Regression in Oligometastatic Patients
A Ottaiano, RP de Vera d’Aragona, AM Trotta, M Santorsola, ...Frontiers in Immunology 13, 898561, 2022202
4
2022
Initial tumour burden and hidden oligometastatic disease in phase 3 clinical trials
Initial tumour burden and hidden oligometastatic disease in phase clinical trialsA Ottaiano, M Santorsola, F Caracò, M Caraglia, G NastiThe Lancet Oncology 2 (4), 452-454, 2022202
3
2022
COVID-19 outbreak: The north versus south epidemiologic Italian paradigm
A Ottaiano, M Santorsola, M Tamburini, F Corrado, M Scrima, M Bocchetti, ...Journal of Epidemiology and Global Health 11 (), 25, 2021202
3
2021